Loading…
AksharChem India (AKSHARCHEM)₹368.20+2.41%Dyes And Pigments
In the Mar 2026 quarter (standalone), AksharChem India reported sales of ₹106 Cr, up 16.5% from Mar 2025, and net profit of ₹4.83 Cr, up 250.0% year on year. For the year to Mar 2026, sales were ₹372 Cr and net profit ₹0 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 71.67 | 73.33 | 75.24 | 81.70 | 85.88 | 78.89 | 90.64 | 90.71 | 96.99 | 89.29 | 80.39 | 106 |
| Expenses | 72.38 | 76.64 | 70.38 | 81.40 | 79.77 | 73.00 | 84.53 | 84.59 | 90.67 | 87.07 | 77.57 | 101 |
| Operating Profit | −0.68 | −3.21 | 4.95 | 0.44 | 6.25 | 6.03 | 6.33 | 6.28 | 6.43 | 2.36 | 2.94 | 5.31 |
| OPM % | −0.9% | −4.4% | 6.5% | 0.5% | 7.2% | 7.6% | 6.9% | 6.9% | 6.6% | 2.6% | 3.6% | 5.0% |
| Other Income | 0.03 | 0.01 | 0.27 | 0.09 | 0.05 | 0.21 | 0.06 | −0.08 | 0.03 | 1.72 | 0.04 | 0.07 |
| Interest | 0.79 | 0.87 | 0.97 | 1.06 | 1.24 | 1.31 | 1.33 | 1.35 | 1.42 | 1.37 | 1.84 | 2.14 |
| Depreciation | 3.34 | 3.48 | 3.46 | 3.46 | 3.45 | 3.50 | 3.50 | 3.51 | 3.98 | 4.10 | 4.18 | 4.22 |
| Profit before tax | −4.79 | −7.56 | 0.78 | −4.02 | 1.60 | 1.42 | 1.55 | 1.31 | 1.04 | −1.42 | −3.08 | −1.01 |
| Tax % | 12.5% | 0.8% | 57.1% | 50.3% | 27.6% | 26.2% | 22.1% | −7.0% | 31.0% | −2.9% | 50.5% | −584.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 0.00 |
| Net Profit | −5.37 | −7.59 | 0.32 | −6.01 | 1.14 | 1.03 | 1.18 | 1.38 | 0.70 | −1.36 | −4.61 | 4.83 |
| EPS (Rs) | −6.69 | −9.45 | 0.40 | −7.47 | 1.42 | 1.28 | 1.47 | 1.72 | 0.87 | −1.70 | −5.74 | 6.02 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 188 | 248 | 264 | 323 | 260 | 246 | 380 | 335 | 302 | 346 | 372 | 372 |
| Expenses | 155 | 171 | 223 | 288 | 234 | 223 | 349 | 319 | 301 | 321 | 355 | 356 |
| Operating Profit | 32.07 | 78.18 | 42.12 | 34.08 | 26.06 | 24.06 | 32.08 | 15.02 | 2.01 | 25.04 | 17.03 | 17.04 |
| OPM % | 16.9% | 31.0% | 15.9% | 10.9% | 9.9% | 9.9% | 8.0% | 4.6% | 0.5% | 7.0% | 4.6% | 4.6% |
| Other Income | 0.99 | 8.98 | 6.98 | 4.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 1.99 | 1.86 |
| Interest | 2.99 | 2.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 2.99 | 3.99 | 4.99 | 6.99 | 6.77 |
| Depreciation | 3.99 | 4.99 | 4.99 | 5.98 | 6.97 | 6.97 | 11.96 | 12.95 | 13.95 | 13.95 | 16.95 | 16.48 |
| Profit before tax | 26.06 | 79.22 | 43.07 | 33.05 | 19.04 | 17.04 | 18.05 | 0.00 | −16.05 | 6.02 | −4.01 | −4.47 |
| Tax % | 35.9% | 32.9% | 27.9% | 32.0% | 18.0% | 28.0% | 11.0% | 88.0% | 20.0% | 17.9% | −90.1% | — |
| Exceptional items | 0.99 | 3.99 | 0.99 | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 1.99 |
| Net Profit | 16.95 | 52.88 | 30.93 | 22.95 | 15.97 | 11.97 | 15.95 | −0.99 | −18.97 | 4.98 | 0.00 | −0.44 |
| EPS (Rs) | 22.73 | 72.30 | 37.22 | 27.51 | 19.12 | 15.23 | 19.77 | −1.16 | −23.20 | 5.93 | −0.54 | −0.55 |
| Dividend payout % | 15.1% | 5.0% | 9.0% | 13.1% | 18.0% | 23.0% | 3.0% | −42.9% | −2.0% | 13.0% | −91.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.01 | 6.99 | 6.99 | 8.01 | 8.01 | 8.00 | 8.00 | 8.00 | 8.02 | 8.02 | 8.01 | 8.02 |
| Reserves | 63.89 | 77.87 | 133 | 230 | 249 | 257 | 271 | 272 | 270 | 251 | 256 | 254 |
| Borrowings | 23.91 | 30.92 | 31.87 | 0.00 | 11.97 | 12.97 | 14.95 | 49.89 | 24.95 | 51.87 | 66.89 | 108 |
| Other Liabilities | 51.17 | 39.19 | 47.16 | 61.11 | 47.23 | 45.21 | 62.30 | 76.36 | 62.30 | 70.33 | 85.41 | 82.39 |
| Total Liabilities | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 452 |
| Fixed Assets | 55.08 | 56.09 | 65.04 | 86.06 | 126 | 128 | 229 | 231 | 225 | 235 | 232 | 287 |
| CWIP | 2.01 | 3.99 | 8.99 | 26.01 | 30.99 | 61.99 | 6.01 | 16.01 | 16.99 | 10.99 | 45.02 | 7.99 |
| Investments | 17.92 | 21.90 | 50.81 | 76.65 | 20.93 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 70.97 | 71.99 | 93.89 | 110 | 138 | 131 | 120 | 159 | 122 | 135 | 139 | 156 |
| Inventories | 18.07 | 16.05 | 32.09 | 30.11 | 37.10 | 42.13 | 58.18 | 72.30 | 59.21 | 65.17 | 70.26 | 73.26 |
| Trade receivables | 20.98 | 22.97 | 12.99 | 27.93 | 37.91 | 29.93 | 27.96 | 52.94 | 35.95 | 46.91 | 40.93 | 61.91 |
| Cash & equivalents | 0.99 | 0.99 | 3.99 | 4.99 | 1.99 | 1.99 | 2.99 | 1.99 | 1.99 | 2.99 | 1.99 | 1.99 |
| Total Assets | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 452 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 27.89 | 12.95 | 40.82 | 29.87 | −8.96 | 25.91 | 48.84 | 3.98 | 37.83 | −6.98 | 34.84 | 1.99 |
| Cash from investing activity | −13.04 | −11.03 | −32.11 | −63.23 | −2.01 | −20.05 | −49.18 | −24.07 | −8.03 | −16.05 | −44.10 | −36.12 |
| Cash from financing activity | −15.04 | −2.01 | −5.01 | 33.05 | 7.02 | −7.02 | 1.01 | 18.03 | −30.07 | 23.05 | 9.01 | 34.09 |
| Net cash flow | 0.00 | 0.00 | 2.99 | 0.00 | −4.01 | 0.00 | 0.99 | −1.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 5.39 | 8.09 | 15.01 | 44.44 | 50.78 | 40.11 | 51.52 | 24.94 | 8.91 | 16.83 | 44.25 | 36.00 |
| Free cash flow | 22.94 | 4.99 | 25.92 | −13.97 | −59.89 | −13.98 | −1.99 | −19.95 | 28.93 | −22.97 | −8.98 | −33.95 |
| CFO / OP % | 124.0% | 65.9% | 80.0% | 101.9% | 1.0% | 116.0% | 211.0% | 27.0% | 255.0% | −759.0% | 141.0% | 11.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 38 | 44 | 20 | 38 | 43 | 42 | 42 | 51 | 39 | 57 | 43 | 61 |
| Inventory days | 53 | 54 | 102 | 68 | 65 | 104 | 148 | 115 | 99 | 131 | 130 | 119 |
| Days payable | 111 | 96 | 100 | 70 | 49 | 62 | 97 | 80 | 64 | 88 | 106 | 88 |
| Cash conversion cycle | −18 | 3 | 23 | 36 | 60 | 84 | 94 | 87 | 76 | 101 | 68 | 93 |
| Working capital days | 8 | 28 | 31 | 56 | 85 | 104 | 75 | 62 | 69 | 55 | 18 | −4 |
| ROCE % | 33.9% | 26.9% | 52.9% | 21.0% | 13.0% | 7.0% | 6.0% | 6.0% | 1.0% | −4.0% | 3.0% | 0.0% |
For the Mar 2026 quarter, AksharChem India reported sales of ₹106 Cr, up 16.5% year on year and net profit of ₹4.83 Cr, up 250.0% year on year. The operating margin was 5.0%.
AksharChem India's sales for the year to Mar 2026 were ₹372 Cr; over the last twelve months they were ₹372 Cr.
Net profit for the year to Mar 2026 was ₹0 Cr, and −₹0.44 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.55.
AksharChem India reported borrowings of ₹108 Cr at Mar 2026, against cash and equivalents of ₹1.99 Cr.
Cash from operations was ₹1.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹33.95 Cr.